We are live on
!
Find out more
JLBC
J.L. Bainbridge & Co Portfolio holdings
AUM
$1.27B
1-Year Est. Return
26.55%
This Fund
S&P 500
This Quarter
Est. Return
+14.92%
1 Year Est. Return
+26.55%
3 Year Est. Return
+93.81%
5 Year Est. Return
+120.16%
10 Year Est. Return
–
AUM
$817M
AUM Growth
+$71M
(+9.5%)
Cap. Flow
-$32.7M
Cap. Flow
% of AUM
-4%
Top 10 Holdings %
Top 10 Hldgs %
62.95%
Holding
91
New
9
Increased
27
Reduced
29
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$7.55M |
| 2 |
nVent Electric
NVT
|
+$6.42M |
| 3 |
Blackstone
BX
|
+$3.9M |
| 4 |
Eli Lilly
LLY
|
+$1.7M |
| 5 |
AbbVie
ABBV
|
+$269K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$20.8M |
| 2 |
Comcast
CMCSA
|
+$16.3M |
| 3 |
Microsoft
MSFT
|
+$2.57M |
| 4 |
Warner Bros
WBD
|
+$2.23M |
| 5 |
Target
TGT
|
+$1.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.04% |
| 2 | Industrials | 19.55% |
| 3 | Communication Services | 14.15% |
| 4 | Financials | 11.85% |
| 5 | Healthcare | 7.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
NVIDIA
NVDA
$5.25T
| $218K | 0.03% |
4,410
-300
| -6% | -$13.9K |
|
77
iShares Core S&P Small-Cap ETF
IJR
$110B
| $211K | 0.03% |
+1,946
| New | +$188K |
|
78
Schwab U.S Small- Cap ETF
SCHA
$22.7B
| $208K | 0.03% |
+8,808
| New | +$186K |
|
79
Altria Group
MO
$115B
| $208K | 0.03% |
5,145
+124
| +2% | +$5.13K |
|
80
Xylem
XYL
$26B
| $206K | 0.03% |
+1,800
| New | +$180K |
|
81
Salesforce
CRM
$211B
| $203K | 0.02% |
+771
| New | +$174K |
|
82
Rayonier Advanced Materials
RYAM
$582M
| $183K | 0.02% |
45,176
-19,489
| -30% | -$64.1K |
|
83
Atossa Therapeutics
ATOS
$25.7M
| $9.79K | ﹤0.01% |
741
| – | – |
|
84
CALL
Alphabet (Google) Class C
GOOG
$4.19T
| $5.64K | ﹤0.01% |
40,000
| – | – |
|
|
85
CALL
Cigna
CI
$73.7B
| $3K | ﹤0.01% |
+10,000
| New | +$2.92M |
|
86
CALL
General Motors
GM
$75.7B
| $1.8K | ﹤0.01% |
50,000
| – | – |
|
87
CALL
Delta Air Lines
DAL
$52.7B
| $1.61K | ﹤0.01% |
40,000
| – | – |
|
|
88
CALL
Microsoft
MSFT
$3.81T
| $940 | ﹤0.01% |
2,500
| – | – |
|
89
Pfizer
PFE
$159B
| – | – |
-6,040
| Closed | -$200K |
|
|
90
CALL
AT&T
T
$178B
| – | – |
-10,000
| Closed | -$150 |
|
|
IBDO
91
DELISTED
iShares iBonds Dec 2023 Term Corporate ETF
IBDO
| – | – |
-41,013
| Closed | -$1.04M |
|
Similar funds
KA
BFS
CFM
JMFC
WA
CAM
JTWM
FG
J.L. Bainbridge & Co's Q4 2023 Portfolio in Review
As of Q4 2023, J.L. Bainbridge & Co held 91 positions worth $817M, up 9.5% from $746M the previous quarter. Its ten largest holdings account for 63% of the portfolio.
J.L. Bainbridge & Co withdrew a net $32.7M in Q4 2023, closing 3 positions and reducing 29 holdings. Its most notable exit was iShares iBonds Dec 2023 Term Corporate ETF, an estimated $1.04M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 36% a quarter earlier, followed by Industrials and Communication Services.
Against the trend, J.L. Bainbridge & Co opened a new position in AbbVie worth $286K.
- J.L. Bainbridge & Co's largest Q4 2023 buy was AbbVie: 1,845 shares worth $286K.
- J.L. Bainbridge & Co added most to Cigna in Q4 2023, an estimated $7.55M increase.
- J.L. Bainbridge & Co's biggest Q4 2023 reduction was AT&T, cutting an estimated $20.8M.
- J.L. Bainbridge & Co fully exited iShares iBonds Dec 2023 Term Corporate ETF in Q4 2023, selling an estimated $1.04M.
- J.L. Bainbridge & Co's ten largest holdings make up 63% of its $817M portfolio in Q4 2023.
- J.L. Bainbridge & Co opened 9 new positions and closed 3 in Q4 2023.
- J.L. Bainbridge & Co's portfolio value rose 9.5% quarter-over-quarter to $817M.
Based on J.L. Bainbridge & Co's 13F filing for Q4 2023, filed 12 Feb 2024.